reglab/housing_qa huggingface dataset:
WV Code § 16-54-3 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 54. Opioid Reduction Act|§16-54-3. Opioid Prescription Notifications

Prior to issuing a prescription for a Schedule II opioid drug, a practitioner shall:(1) Advise the patient regarding the quantity of the Schedule II opioid drug and a patients option to fill the prescription in a lesser quantity; and (2) Inform the patient of the risks associated with the Schedule II opioid drug prescribed.
WV Code § 16-54-5 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 54. Opioid Reduction Act|§16-54-5. Subsequent Prescriptions; Limitations

(a) After issuing the initial Schedule II opioid drug prescription as set forth in §16-54-4 of this code, the practitioner, after consultation with the patient, may issue a subsequent prescription for a Schedule II opioid drug to the patient if:(1) The subsequent prescription would not be deemed an initial prescription pursuant to §16-54-4 of this code;(2) The practitioner determines the prescription is necessary and appropriate to the patients treatment needs and documents the rationale for the issuance of the subsequent prescription; and(3) The practitioner determines that issuance of the subsequent prescription does not present an undue risk of abuse, addiction, or diversion and documents that determination.(b) Prior to issuing the subsequent Schedule II opioid drug prescription of the course of treatment, a practitioner shall discuss with the patient, or the patients parent or guardian if the patient is under 18 years of age, the risks associated with the Schedule II opioid drugs being prescribed. This discussion shall include: (1) The risks of addiction and overdose associated with Schedule II opioid drugs and the dangers of taking Schedule II opioid drugs with alcohol, benzodiazepines, and other central nervous system depressants;(2) The reasons why the prescription is necessary; (3) Alternative treatments that may be available; and(4) Risks associated with the use of the Schedule II opioid drug being prescribed, specifically that Schedule II opioid drugs are highly addictive, even when taken as prescribed, that there is a risk of developing a physical or psychological dependence on the Schedule II opioid drug, and that the risks of taking more opioids than prescribed, or mixing sedatives, benzodiazepines, or alcohol with opioids, can result in fatal respiratory depression. (c) The discussion as set forth in §16-54-5(b) of this code shall be included in a notation in the patients medical record.
WV Code § 16-54-6 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 54. Opioid Reduction Act|§16-54-6. Ongoing Treatment; Referral to Pain Clinic or Pain Specialist

(a) At the time of the issuance of the third prescription for a Schedule II opioid drug the practitioner shall consider referring the patient to a pain clinic or a pain specialist. The practitioner shall discuss the benefits of seeking treatment through a pain clinic or a pain specialist and provide him or her with an understanding of any risks associated by choosing not to pursue that as an option.(b) If the patient declines to seek treatment from a pain clinic or a pain specialist and opts to remain a patient of the practitioner, and the practitioner continues to prescribe a Schedule II opioid drug as provided in this code, the practitioner shall:(1) Note in the patients medical records that the patient knowingly declined treatment from a pain clinic or pain specialist; (2) Review, at a minimum of every three months, the course of treatment, any new information about the etiology of the pain, and the patients progress toward treatment objectives and document the results of that review;(3) Assess the patient prior to every renewal to determine whether the patient is experiencing problems associated with physical and psychological dependence and document the results of that assessment; and(4) Periodically make reasonable efforts, unless clinically contraindicated, to either stop the use of the controlled substance, decrease the dosage, try other drugs or treatment modalities in an effort to reduce the potential for abuse or the development of physical or psychological dependence, and document with specificity the efforts undertaken.
WV Code § 16-54-7 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 54. Opioid Reduction Act|§16-54-7. Exceptions

(a) This article does not apply to a patient who is currently in active treatment for cancer, receiving hospice care from a licensed hospice provider or palliative care provider, or is a resident of a long-term care facility. (b) This article does not apply to a patient being prescribed, or ordered, any medication in an inpatient setting at a hospital.(c) Notwithstanding the limitations on the prescribing of a Schedule II opioid drug contained in §16-54-4 of this code, a practitioner may prescribe an initial seven-day supply of a Schedule II opioid drug to a post-surgery patient immediately following a surgical procedure. Based upon the medical judgment of the practitioner, a subsequent prescription may be prescribed by the practitioner pursuant to the provisions of this code. Nothing in this section authorizes a practitioner to prescribe any medication which he or she is not permitted to prescribe pursuant to their practice act.(d) A practitioner who acquires a patient after January 1, 2018, who is currently being prescribed a Schedule II opioid drug from another practitioner is required to access the Controlled Substances Monitoring Program Database as set forth in §60A-9-1 et seq. of this code. The practitioner shall otherwise treat the patient as set forth in this code.(e) This article does not apply to an existing practitioner-patient relationship established before January 1, 2018, where there is an established and current opioid treatment plan which is reflected in the patients medical records.
WV Code § 16-54-8 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 54. Opioid Reduction Act|§16-54-8. Treatment of Pain

(a) When a patient seeks treatment, a health care practitioner shall refer or prescribe to the patient any of the following treatment alternatives, as is appropriate based on the practitioners clinical judgment and the availability of the treatment, before starting a patient on a Schedule II opioid drug: physical therapy, occupational therapy, acupuncture, massage therapy, osteopathic manipulation, chronic pain management program, and chiropractic services, as defined in §30-16-3 of this code. (b) Nothing in this section should be construed to require that all of the treatment alternatives set forth in §16-54-8(a) of this code are required to be exhausted prior to the patients receiving a prescription for a Schedule II opioid drug. (c) At a minimum, an insurance provider who offers an insurance product in this state, the Bureau for Medical Services, and the Public Employees Insurance Agency shall provide coverage for 20 visits per event of physical therapy, occupational therapy, osteopathic manipulation, a chronic pain management program, and chiropractic services, as defined in §30-16-3 of this code, when ordered or prescribed by a health care practitioner. (d) A person may seek physical therapy, occupational therapy, osteopathic manipulation, a chronic pain management program, and chiropractic services, as defined in §30-16-3 of this code, prior to seeking treatment from any other health care practitioner. The licensed health care practitioner providing services pursuant to this section may prescribe within their scope of practice as defined in §16-54-1 of this code. A health care practitioner referral although permitted is not required as a condition of coverage by the Bureau for Medical Services the Public Employees Insurance Agency, and any insurance provider who offers an insurance product in this state. Any deductible, coinsurance, or copay required for any of these services may not be greater than the deductible, coinsurance, or copay required for a primary care visit. (e) Nothing in this section precludes a practitioner from simultaneously prescribing a Schedule II opioid drug and prescribing or recommending any of the procedures set forth in §16-54-8(a) of this code.
WV Code § 16-54-9 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 54. Opioid Reduction Act|§16-54-9. Discipline

A violation of this article is grounds for disciplinary action by the board that regulates the health care practitioner who commits the violation.
WV Code § 16-55-1 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 55. State Advisory Coalition on Palliative Care|§16-55-1. Purpose

The purpose of the coalition created under this article is to improve quality and delivery of patient centered and family focused palliative care in West Virginia.
WV Code § 16-55-2 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 55. State Advisory Coalition on Palliative Care|§16-55-2. Definitions

As used in this article:“Appropriate” means consistent with applicable legal, health, and professional standards; the patient’s clinical and other circumstances; and the patient’s reasonably known wishes and beliefs.“Medical care” means services provided, requested, or supervised by a physician or advanced practice nurse. “Palliative care” means patient and family centered medical care that optimizes quality of life by anticipating, preventing, and treating suffering caused by serious illness throughout the continuum of illness, involves addressing physical, emotional, social, and spiritual needs, and facilitates patient autonomy, access to information, and choice. “Serious Illness” means any medical illness or physical injury or condition that substantially impacts quality of life for more than a short time.
WV Code § 16-55-3 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 55. State Advisory Coalition on Palliative Care|§16-55-3. Creation of the State Advisory Coalition on Palliative Care

There is created the State Advisory Coalition on Palliative Care. The administrative functions of the coalition are the responsibility of staff assigned to the Joint Committee on Health.
WV Code § 16-55-4 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 55. State Advisory Coalition on Palliative Care|§16-55-4. Members of the Advisory Coalition on Palliative Care

(a) The Advisory Coalition on Palliative Care consists of the individuals appointed by the President of the Senate and the Speaker of the House of Delegates who are health professionals having palliative care work experience and/or expertise in palliative care delivery models in a variety of inpatient, outpatient, and community settings and with a variety of populations, including pediatric, youth, and adults.(b) The members include:(1) A physician who practices palliative care in this state and is licensed pursuant to the provisions of §30-3-1 et seq. of this code, who shall serve as chair of the coalition for the first meeting until a chairman is selected by the Advisory Coalition;(2) A physician;(3) A registered professional nurse;(4) A social worker;(5) A pharmacist;(6) A spiritual advisor;(7) A patient advocate;(8) A family caregiver advocate;(9) One additional palliative care practitioner; and (10) The Executive Director of the Center for End of Life Care, or his or her designee. (c) The co-chairs of the Joint Committee on Health serve as nonvoting members, ex-officio.(d) Membership on the coalition shall be distributed among the congressional districts of the state, and each congressional district shall be represented in the membership of the coalition.
WV Code § 16-55-5 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 55. State Advisory Coalition on Palliative Care|§16-55-5. Powers and Duties

(a) The coalition shall consult with and advise the Legislature on matters related to the establishment, maintenance, operation, and outcomes evaluation of palliative care initiatives in the state. The coalition may:(1) Meet at least quarterly or at the call of the chairman. A quorum is a simple majority of the coalition;(2) Keep accurate records of the actions of the coalition; (3) Make recommendations to the Legislature as required by this article;(4) Provide guidance to the Legislature on potential statutory solutions relative to regulation of palliative care;(5) Establish workgroups and clinical advisory committees as the coalition considers necessary to address pertinent issues related to palliative care and to provide consistency in the development of further regulation;(6) Consult with entities and persons with expertise as the coalition considers necessary in the fulfillment of its duties. This can include public and private sector partnerships; (7) Establish a system for identifying patients or residents who could benefit from palliative care; (8) Provide information about and facilitate access to appropriate palliative care; and(9) Offer any additional guidance to the Legislature which the coalition sees is within its scope which would further enhance the palliative care.(b) The coalition shall report its findings to the Joint Committee on Health by December 31, 2019, and annually after that until the coalition terminates pursuant to the provisions of this article. The report shall include, at a minimum, the following:(1) Conclusions and recommendations to promote a better means for palliative care;(2) Recommendations for statutory and regulatory modifications;(3) Identification of any action which may be taken by the Legislature to better foster awareness of palliative care issues in this state;(4) A means to raise palliative care awareness; and(5) Any other ancillary issues relative to palliative care.
WV Code § 16-55-6 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 55. State Advisory Coalition on Palliative Care|§16-55-6. Cooperation With the Coalition

The Department of Health and Human Resources, the West Virginia Insurance Commission, the Public Employees Insurance Agency, the Center for End of Life Care, and all other entities of state government shall cooperate with the coalition in the exchange of data, information, and expertise if so requested by the coalition, including, but not limited to:(1) Providing the entity’s plans to improve palliative care in West Virginia;(2) Sharing information on the financial impact of palliative care on the State of West Virginia;(3) Providing an assessment of the benefits of implemented programs and activities aimed at bettering palliative care; (4) Assisting in the development or revision of detailed action plans to improve palliative care; and(5) Providing resources required to implement the plan.
WV Code § 16-55-7 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 55. State Advisory Coalition on Palliative Care|§16-55-7. Sunset

The coalition terminates on December 31, 2021, unless continued by act of the Legislature.
WV Code § 16-56-1 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 56. Tobacco Cessation Therapy Access Act|§16-56-1. Definitions

As used in this article:"Dispense" means the same as that term is defined in §30-5-4 of this code."Patient counseling" means the same as that term is defined in §30-5-4 of this code."Pharmacist" means the same as that term is defined in §30-5-4 of this code."Pharmacy intern" means the same as that term is defined in §30-5-4 of this code."Physician" means the same as that term is defined in §30-3E-1 of this code."Tobacco cessation therapy" means a tobacco cessation noncontrolled prescription medication, over-the-counter medication or other professional service, that is approved by the United States Food and Drug Administration for treating tobacco use including all of the of various dosage forms.
WV Code § 16-56-2 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 56. Tobacco Cessation Therapy Access Act|§16-56-2. Voluntary Participation

This article does not create a duty or standard of care for a person to prescribe or dispense tobacco cessation therapy.
WV Code § 16-56-3 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 56. Tobacco Cessation Therapy Access Act|§16-56-3. Authorization to Dispense

A pharmacist licensed under §30-5-1 et seq. of this code may initiate and dispense a noncontrolled prescription medication, over-the-counter medication, or other professional service to a patient who is 18 years old or older; pursuant to a standing prescription drug order made in accordance with §16-56-4 of this code without any other prescription drug order from a person licensed to prescribe a tobacco cessation therapy; and in accordance with the dispensing guidelines in §16-56-6 of this code.
WV Code § 16-56-4 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 56. Tobacco Cessation Therapy Access Act|§16-56-4. Standing Prescription Drug Orders for Tobacco Cessation Therapy

(a) The Commissioner of the Bureau for Public Health or designee shall prescribe on a statewide basis a tobacco cessation therapy by one or more standing orders permitting pharmacists to initiate the dispensing of noncontrolled prescription medications, over-the-counter medications, or other professional services to eligible individuals: (b) A standing order must specify, at a minimum:(1) Use of the Tobacco Cessation Therapy Protocol, that has been approved by the Commissioner of the Bureau for Public Health in collaboration with the Board of Pharmacy and the Board of Medicine;(2) The eligible individuals to whom the tobacco cessation therapy may be dispensed;(3) The timeline for renewing and updating the standing order.
WV Code § 16-56-5 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 56. Tobacco Cessation Therapy Access Act|§16-56-5. Pharmacist Education and Training Required

The Board of Pharmacy shall approve a training program or programs to be eligible to participate in the utilization of the standing prescription drug order for tobacco cessation therapy by a pharmacist.Documentation shall be provided to the Board of Pharmacy upon request.
WV Code § 16-56-6 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 56. Tobacco Cessation Therapy Access Act|§16-56-6. Guidelines for Dispensing a Tobacco Cessation Therapy

(a) A pharmacist who dispenses a tobacco cessation therapy under this article shall follow the Tobacco Cessation Therapy Protocol, that has been approved by the Commissioner of the Bureau for Public Health in collaboration with the Board of Pharmacy and the Board of Medicine, before dispensing the tobacco cessation therapy. The protocol shall include the:(1) Criteria for identifying individuals eligible to receive the tobacco cessation therapy or other professional services under the protocol, and referral to an appropriate prescriber if the patient is high-risk or therapy is contraindicated;(2) Medications authorized by the protocol;(3) Procedures for initiation and monitoring of therapies, including a care plan based on clinical guidelines;(4) Education requirements to be provided to the person receiving the medications and follow-up care;(5) Documentation procedures in the pharmacy system; and(6) Notification of the individuals primary care provider, if provided, within two business days. (b) If when following the protocol it is indicated that it is unsafe to dispense a tobacco cessation therapy to a patient, the pharmacist: (A) May not dispense a tobacco cessation therapy to the patient; and(B) Shall refer the patient to their primary care provider.(c) The Board of Pharmacy regulates a pharmacist who dispenses a tobacco cessation noncontrolled prescription medication, over-the-counter medication, or other professional service.
WV Code § 16-57-1 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 57. Sudden Cardiac Arrest Prevention Act|§16-57-1. Purpose

This article shall be known and may be cited as the Sudden Cardiac Arrest Prevention Act. In the United States there are more than 356,000 out-of-hospital cardiac arrests annually and nearly 90 percent of them are fatal. The purpose of this article is to promote education regarding sudden cardiac arrest and thereby prevent sudden cardiac arrest from occurring.
WV Code § 16-57-2 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 57. Sudden Cardiac Arrest Prevention Act|§16-57-2. Definitions

The following words and phrases when used in this article have the meanings given to them in this section unless the context clearly indicates otherwise."Athletic activity" means all the following:(a) Interscholastic athletics;(b) An athletic contest or competition that is sponsored by or associated with a school entity, including cheerleading, club-sponsored sports activities, and sports activities sponsored by school-affiliated organizations;(c) Noncompetitive cheerleading that is sponsored by school-affiliated organizations; and(d) Practices, interschool practices, and scrimmages for all of the activities described in this section."School" means any school under the jurisdiction of a county board of education.
WV Code § 16-57-4 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 57. Sudden Cardiac Arrest Prevention Act|§16-57-4. Rulemaking

The Department of Education, acting in conjunction with the Department of Health and Human Resources, may propose rules for legislative approval in accordance with §29A-3-1 et seq. of this code that are necessary to effectuate the provisions of this article.
WV Code § 16-58-1 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 58. Family Planning Access Act|§16-58-1. Definitions

As used in this article:"Dispense" means the same as that term is defined in §30-5-4 of this code."Patient counseling" means the same as that term is defined in §30-5-4 of this code."Pharmacist" means the same as that term is defined in §30-5-4 of this code."Self-administered hormonal contraceptive" means a self-administered hormonal contraceptive that is approved by the United States Food and Drug Administration to prevent pregnancy and does not include the class of emergency contraceptives commonly known as the "morning after pill" or "Plan B".
WV Code § 16-58-2 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 58. Family Planning Access Act|§16-58-2. Voluntary Participation

This article does not create a duty or standard of care for a person to prescribe or dispense a self-administered hormonal contraceptive.
WV Code § 16-58-3 (2021)
2021 West Virginia Code|Chapter 16. Public Health|Article 58. Family Planning Access Act|§16-58-3. Authorization to Dispense Self-Administered Hormonal Contraceptives

(a) A pharmacist licensed under §30-5-1 et seq. of this code may dispense a self-administered hormonal contraceptive: (1) pursuant to a standing prescription drug order made in accordance with §16-57-4 of this code without any other prescription drug order from a person licensed to prescribe a self-administered hormonal contraceptive; (2) in accordance with the dispensing guidelines in §16-57-6 of this code; and (3) to a patient who is 18 years old or older.(b) All state and federal laws governing insurance coverage of contraceptive drugs, devices, products, and services shall apply to self-administered contraceptives dispensed by a pharmacist under a standing order pursuant to this section.